問卷

TPIDB > Principal Investigator

Principal Investigator


Taichung Veterans General Hospital (在職)

Division of Orthopedics

更新時間:2023-09-19

周育誠
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

3Cases

2019-03-01 - 2026-12-31

Phase II

Active
A Phase II, Randomized, Open-Label, Parallel-Group Autologous Dendritic Cell Vaccination as an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients
  • Condition/Disease

    Glioblastoma Multiforme (GBM)

  • Test Drug

    ADCV01

Participate Sites
4Sites

Recruiting3Sites

Terminated1Sites

2017-10-01 - 2026-12-31

Others

Active
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Terminated3Sites

2015-05-01 - 2020-06-11

Phase II

ABT-414 alone or ABT-414 plus temozolomide versus lomustine or temozolomide for recurrent glioblastoma: a randomized phase II study of the EORTC Brain Tumor Group
  • Condition/Disease

    Glioblastoma Multiforme (GBM)

  • Test Drug

    ABT-414

Participate Sites
5Sites

Terminated5Sites